ROME (Reuters) - Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims.
The court's decision flies in the face of much scientific opinion, which generally says there is not enough evidence to declare a link between mobile phone use and diseases such as cancer and some experts said the Italian ruling should not be used to draw wider conclusions about the subject.
"Great caution is needed before we jump to conclusions about mobile phones and brain tumors," said Malcolm Sperrin, director of medical physics and clinical engineering at Britain's Royal Berkshire Hospital.
The Italian case concerned company director Innocenzo Marcolini who developed a tumor in the left side of his head after using his mobile phone for 5-6 hours a day for 12 years. He normally held the phone in his left hand, while taking notes with his right hand.
Marcolini developed a so-called neurinoma affecting a cranial nerve, which was apparently not cancerous but nevertheless required surgery that badly affected his quality of life.
He initially sought financial compensation from the Italian Workers' Compensation Authority INAIL which rejected his application, saying there was no proof his illness had been caused by his work.
But a court in Brescia later ruled there was a causal link between the use of mobile and cordless telephones and tumors.
Italy's supreme court rejected an INAIL appeal against that ruling on October 12 though its decision was only reported on Friday.
It said the lower court's decision was justified and that scientific evidence advanced in support of the claim was reliable. Marcolini's situation had been "different from normal, non-professional use of a mobile telephone", it said.
The evidence was based on studies conducted between 2005-2009 by a group led by Lennart Hardell, a cancer specialist at the University Hospital in Orebro in Sweden. The court said the research was independent and "unlike some others, was not co-financed by the same companies that produce mobile telephones".
(Reporting By Virginia Alimenti; Additional reporting by Naomi O'Leary and Kate Kelland in London; Editing by Andrew Osborn)
Source: http://news.yahoo.com/italy-court-ruling-links-mobile-phone-tumor-151756598.html
If you don’t know about Startup Health and you’re a healthtech investor or entrepreneur (or at all interested in the space, you need to rectify that. After all, as evidenced by the launch of another solid, differentiated health-focused startup accelerator last week, there is a lot of public, private and entrepreneurial attention shifting to the industry. Compared to the majority of business incubators, Startup Health has an unusual model, as it doesn’t offer seed investments and its startups stay enrolled in its program for three years. Rather focusing on demo days or seed rounds, Startup Health wants to help founders build a sustainable, growth business by providing a support structure, classes, courses (and a structured curriculum), a collaborative peer network and access to potential partners, customers and mentors. The accelerator also works with sponsors, like AT&T and the California Healthcare Foundation, to provide scholarships that help cover the costs of the program. These sponsors and partners also provide potential funding channels for startups, as many of them operate in the space and can help provide beta testers and capital that allow teams to test products and models. Startup Health takes two to ten percent equity in its companies, determining its stake based on how much it can improve their key metrics over the course of the three-year program, like revenue, team size, partnerships, key customer relationships, product success and fundraising. Last month, Jordan sat down with Startup Health co-founder Unity Stoakes to dig into the accelerator’s model and discuss, among other things, its addition of 12 more startups to its roster, bringing the total to 22. Now, even if you’re a naysayer and don’t find much in Startup Health’s arsenal to write home about, it’s hard not to see the value in the accelerator’s latest announcement. Today, Startup Health opened up access to the “Startup Health Network,” a platform designed to help improve access to capital, customers and resources — both for healthtech enterpreneurs, investors and knowledge seekers. Said in a sexier (and perhaps more telling way), the Startup Health Network is basically an AngelList for healthtech. With a splash of CrunchBase. At beta launch, the network features more than 1,200 healthtech startups, 700 entrepreneurs, 400 VC firms, 180 angel investors and a litany of customers, partner organizations, payers, providers, pharma companies, foundations, etc. The network also offers users the ability to message each other, but this functionality is only
WebmasterWorld,? Tabke added.
